Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Fluconazole can cause temporary hair loss, which stops after reducing or stopping the drug.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tofacitinib might be used to treat hair loss.

Alefacept does not effectively treat severe alopecia areata.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Combining fluticasone propionate and UV-A is more effective for vitiligo than using either alone.

Topical tacrolimus is effective and safe for treating alopecia areata.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Oral tofacitinib successfully treated total body hair loss in one patient.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Upadacitinib improved multiple immune-related conditions in one patient.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.